Ranibizumab Injection (Susvimo) Implant Septum Dislodgement in a Patient With Neovascular Age-Related Macular Degeneration

JAMA Ophthalmol. 2022 Aug 1;140(8):832. doi: 10.1001/jamaophthalmol.2022.2495.

Authors

Kaitlyn Timmons¹, Luke C Heckmann¹, Yong Ren¹, Ivana Gunderson¹, Fuad Makkouk^{1

2}, Brian B Berger¹

Affiliations

¹ Austin Clinical Research, Austin, Texas.
² Austin Eye Center, Austin, Texas.

PMID: 35834239
DOI: 10.1001/jamaophthalmol.2022.2495

No abstract available

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Humans
Intravitreal Injections
Macular Degeneration* / drug therapy
Ranibizumab / therapeutic use
Wet Macular Degeneration* / diagnosis
Wet Macular Degeneration* / drug therapy

Substances

Angiogenesis Inhibitors
Ranibizumab